Jian Yang
YOU?
Author Swipe
View article: Correction: TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation
Correction: TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation Open
View article: Advancements in nanomedicine for modulating ischemic cardiomyopathy therapy
Advancements in nanomedicine for modulating ischemic cardiomyopathy therapy Open
View article: Role of G-protein-coupled receptor kinase 4 on the dysfunction of renal Mas receptor in hypertension
Role of G-protein-coupled receptor kinase 4 on the dysfunction of renal Mas receptor in hypertension Open
The angiotensin converting enzyme 2/angiotensin-(1–7)/Mas receptor axis plays an important role in the regulation of blood pressure. G protein-coupled receptor kinase 4 (GRK4) has attracted more attentions by modulating G protein-coupled r…
View article: Occult sigmoid–vesical fistula following percutaneous nephrolithotomy in an elderly patient with diverticulosis: A case report and multidisciplinary management approach
Occult sigmoid–vesical fistula following percutaneous nephrolithotomy in an elderly patient with diverticulosis: A case report and multidisciplinary management approach Open
View article: Impact of inferior vena cava thrombosis on the prevalence of pulmonary embolism in patients with lower extremity deep vein thrombosis
Impact of inferior vena cava thrombosis on the prevalence of pulmonary embolism in patients with lower extremity deep vein thrombosis Open
Inferior vena cava thrombosis (IVCT) is a special form of venous thromboembolism. Lower extremity deep vein thrombosis (LEDVT) is associated with an increased incidence of pulmonary embolism (PE), but the association between concomitant IV…
View article: Advances in magnetic resonance imaging of the developing brain and its applications in pediatrics
Advances in magnetic resonance imaging of the developing brain and its applications in pediatrics Open
The human brain undergoes a complex and dynamic developmental process from birth through adolescence, driven by molecular and cellular mechanisms that shape its structure and function. Magnetic resonance imaging (MRI) has become an essenti…
View article: Dietary Intake of Octanoic Acid Restores <scp>UBE3A</scp> Expression and Improves the Behavioral Phenotypes in a Mouse Model of Angelman Syndrome
Dietary Intake of Octanoic Acid Restores <span>UBE3A</span> Expression and Improves the Behavioral Phenotypes in a Mouse Model of Angelman Syndrome Open
Angelman syndrome (AS) is a severe neurodevelopmental disorder with no effective therapies. Most of the behavioral deficits observed in AS patients arise from the absence of ubiquitin protein ligase E3A (UBE3A) in the brain during developm…
View article: Adipokine isthmin-1 is a potential predictor of abnormal urine Na+ excretion and insulin resistance for primary hypertension
Adipokine isthmin-1 is a potential predictor of abnormal urine Na+ excretion and insulin resistance for primary hypertension Open
View article: High-risk factors and predictive models for hemorrhagic chronic radiation proctitis
High-risk factors and predictive models for hemorrhagic chronic radiation proctitis Open
In this study, we constructed and developed a nomogram for predicting hemorrhagic CRP risk. The good results in calibration curves, ROC curve analysis, and decision curves indicated that the nomogram had promise for clinical application. I…
View article: Dopamine receptors and organ fibrosis
Dopamine receptors and organ fibrosis Open
Organ fibrosis, considered as a major global health concern, is a pathological condition often occurring after tissue injury in various organs. The pathogenesis of fibrosis involves multiple phases and multiple cell types. Dopamine is invo…
View article: Imaging measurements of percutaneous posterior quadcortical screw fixation of vertebral bodies
Imaging measurements of percutaneous posterior quadcortical screw fixation of vertebral bodies Open
View article: Impact of inferior vena cava thrombosis on the incidence of pulmonary embolism in patients with lower extremity deep vein thrombosis
Impact of inferior vena cava thrombosis on the incidence of pulmonary embolism in patients with lower extremity deep vein thrombosis Open
Inferior vena cava thrombosis (IVCT) is a special form of venous thromboembolism. Lower extremity deep vein thrombosis (LEDVT) is associated with an increased incidence of pulmonary embolism (PE), but the association between concomitant IV…
View article: Figure S2 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Figure S2 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
Figure. S2. The effects of DHA supplementation for eight weeks on T, B and NK cells without B16F10 injection. WT mice were fed with control or DHA-enriched diets for eight weeks.
View article: Figure S3 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Figure S3 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
Figure. S3. DHA-enriched diet withdrawal at the beginning of tumour injection had a decreased antitumour effect.
View article: Figure S2 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Figure S2 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
Figure. S2. The effects of DHA supplementation for eight weeks on T, B and NK cells without B16F10 injection. WT mice were fed with control or DHA-enriched diets for eight weeks.
View article: Figure S8 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Figure S8 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
Figure. S8. A, Purified splenic NK cells from WT mice were treated with DMSO or 10 μM DHA in the presence of 1000 IU IL-2 plus 10 ng/ml IL-15 or 50 ng/ml IL-15 alone for 10 days and the gMFIs of 2-NBDG were measured in NK cells. B, Purifie…
View article: Data from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Data from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
ω-3 polyunsaturated fatty acids (PUFA) are known to directly repress tumor development and progression. In this study, we explored whether docosahexaenoic acid (DHA), a type of ω-3 PUFA, had an immunomodulatory role in inhibiting tumor gro…
View article: Figure S5 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Figure S5 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
Figure. S5. Subsets of NK cells in lung of control and DHA-treated mice with B16F10 melanoma tumour growth.
View article: Figure S3 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Figure S3 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
Figure. S3. DHA-enriched diet withdrawal at the beginning of tumour injection had a decreased antitumour effect.
View article: Figure S8 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Figure S8 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
Figure. S8. A, Purified splenic NK cells from WT mice were treated with DMSO or 10 μM DHA in the presence of 1000 IU IL-2 plus 10 ng/ml IL-15 or 50 ng/ml IL-15 alone for 10 days and the gMFIs of 2-NBDG were measured in NK cells. B, Purifie…
View article: Figure S1 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Figure S1 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
Figure. S1. The effects of DHA supplementation for three weeks on T, B and NK cells without B16F10 injection. WT mice were fed with control or DHA-enriched diets for three weeks.
View article: Figure S1 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Figure S1 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
Figure. S1. The effects of DHA supplementation for three weeks on T, B and NK cells without B16F10 injection. WT mice were fed with control or DHA-enriched diets for three weeks.
View article: Figure S7 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Figure S7 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
Figure. S7. NK cells were effectively depleted by injecting PK136 antibodies in various tissues. WT Mice were treated as described in Figure. 4E. Flow cytometric analysis and cumulative frequencies of NK cells in the indicated tissues were…
View article: Figure S7 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Figure S7 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
Figure. S7. NK cells were effectively depleted by injecting PK136 antibodies in various tissues. WT Mice were treated as described in Figure. 4E. Flow cytometric analysis and cumulative frequencies of NK cells in the indicated tissues were…
View article: Supplementary Tables S1-S7 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Supplementary Tables S1-S7 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
Supplementary tables
View article: Figure S5 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Figure S5 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
Figure. S5. Subsets of NK cells in lung of control and DHA-treated mice with B16F10 melanoma tumour growth.
View article: Data from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Data from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
ω-3 polyunsaturated fatty acids (PUFA) are known to directly repress tumor development and progression. In this study, we explored whether docosahexaenoic acid (DHA), a type of ω-3 PUFA, had an immunomodulatory role in inhibiting tumor gro…
View article: Figure S6 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Figure S6 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
Figure. S6 NK cells have high absorption capacity for DHA
View article: Figure S4 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Figure S4 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
Figure. S4. The effect of continuous DHA supplementation on T, B and NK cells in mice challenged with B16F10 cell i.v. injection. WT mice were first fed with control or DHA-enriched diets for three weeks and then intravenously (i.v.) injec…
View article: Figure S4 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions
Figure S4 from The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions Open
Figure. S4. The effect of continuous DHA supplementation on T, B and NK cells in mice challenged with B16F10 cell i.v. injection. WT mice were first fed with control or DHA-enriched diets for three weeks and then intravenously (i.v.) injec…